Denali Therapeutics Inc (DNLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 137,434 | 134,963 | 145,580 | 129,846 | 123,187 |
| Operating Income | -137,434 | -134,963 | -145,580 | -129,846 | -123,187 |
| Other Income | 10,532 | 10,844 | 12,610 | 15,161 | 15,995 |
| Pre-tax Income | -126,902 | -124,119 | -132,970 | -114,685 | -107,192 |
| Net Income Continuous | -126,902 | -124,119 | -132,970 | -114,753 | -107,192 |
| Net Income | $-126,902 | $-124,119 | $-132,970 | $-114,753 | $-107,192 |
| EPS Basic Total Ops | -0.74 | -0.72 | -0.78 | -0.67 | -0.63 |
| EPS Basic Continuous Ops | -0.74 | -0.72 | -0.78 | -0.67 | -0.63 |
| EPS Diluted Total Ops | -0.74 | -0.72 | -0.78 | -0.67 | -0.63 |
| EPS Diluted Continuous Ops | -0.74 | -0.72 | -0.78 | -0.67 | -0.63 |
| EPS Diluted Before Non-Recurring Items | -0.74 | -0.72 | -0.78 | -0.67 | -0.63 |
| EBITDA(a) | $-136,513 | $-134,615 | $-147,143 | $-134,158 | $-129,727 |